Soligenix, Inc. (SNGX) stock
SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.28−0.01 (-2.67%)
Close on Nov 17, 2026Market cap $6.11MP/E –Yield –
Soligenix profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Soligenix's profit margin for the twelve months ending Dec 31, 2024 was -6925.1%. For fiscal 2024 it was -6925.1%, against -731.6% the year before. The highest annual figure on record is -31.0% in fiscal 2011.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -6925.1% | −6193.5 |
| FY2023 | Dec 31, 2023 | -731.6% | +722.5 |
| FY2022 | Dec 31, 2022 | -1454.1% | +68.6 |
| FY2021 | Dec 31, 2021 | -1522.7% | −773.0 |
| FY2020 | Dec 31, 2020 | -749.7% | −547.6 |
| FY2019 | Dec 31, 2019 | -202.1% | −32.3 |
| FY2018 | Dec 31, 2018 | -169.8% | −38.2 |
| FY2017 | Dec 31, 2017 | -131.6% | −100.5 |
| FY2016 | Dec 31, 2016 | -31.1% | +58.3 |
| FY2015 | Dec 31, 2015 | -89.3% | +5.9 |
| FY2014 | Dec 31, 2014 | -95.2% | +216.8 |
| FY2013 | Dec 31, 2013 | -312.0% | −179.6 |
| FY2012 | Dec 31, 2012 | -132.4% | −101.3 |
| FY2011 | Dec 31, 2011 | -31.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | -70217.8% | −69438.8 |
| Q1 FY2024 | Mar 31, 2024 | -1636.6% | −1229.9 |
| Q4 FY2023 | Dec 31, 2023 | -743.4% | +282.0 |
| Q3 FY2023 | Sep 30, 2023 | -1274.7% | +717.0 |
| Q2 FY2023 | Jun 30, 2023 | -779.0% | +264.9 |
| Q1 FY2023 | Mar 31, 2023 | -406.8% | +1905.8 |
| Q4 FY2022 | Dec 31, 2022 | -1025.4% | +681.1 |
| Q3 FY2022 | Sep 30, 2022 | -1991.7% | −65.0 |
| Q2 FY2022 | Jun 30, 2022 | -1043.9% | −160.8 |
| Q1 FY2022 | Mar 31, 2022 | -2312.5% | −711.9 |
| Q4 FY2021 | Dec 31, 2021 | -1706.4% | +20.6 |
| Q3 FY2021 | Sep 30, 2021 | -1926.7% | −1632.7 |
| Q2 FY2021 | Jun 30, 2021 | -883.1% | −333.5 |
| Q1 FY2021 | Mar 31, 2021 | -1600.7% | −780.7 |
| Q4 FY2020 | Dec 31, 2020 | -1727.0% | −1583.8 |
| Q3 FY2020 | Sep 30, 2020 | -294.0% | +11.9 |
| Q2 FY2020 | Jun 30, 2020 | -549.5% | −414.8 |
| Q1 FY2020 | Mar 31, 2020 | -820.0% | −729.8 |
| Q1 FY2019 | Mar 31, 2019 | -143.2% | +69.1 |
| Q4 FY2018 | Dec 31, 2018 | -306.0% | −140.0 |
| Q3 FY2018 | Sep 30, 2018 | -134.8% | −81.9 |
| Q2 FY2018 | Jun 30, 2018 | -90.2% | +143.1 |
| Q1 FY2018 | Mar 31, 2018 | -212.3% | −82.0 |
| Q4 FY2017 | Dec 31, 2017 | -166.0% | −146.6 |
| Q3 FY2017 | Sep 30, 2017 | -52.9% | +3.7 |
| Q2 FY2017 | Jun 30, 2017 | -233.3% | −230.3 |
| Q1 FY2017 | Mar 31, 2017 | -130.2% | −86.6 |
| Q4 FY2016 | Dec 31, 2016 | -19.4% | – |
| Q3 FY2016 | Sep 30, 2016 | -56.5% | – |
| Q2 FY2016 | Jun 30, 2016 | -2.9% | – |
| Q1 FY2016 | Mar 31, 2016 | -43.7% | – |
See a number that looks wrong?